
# Statistical Analysis Plan - STUDY001

## 1. Introduction
This document outlines the statistical analysis plan for clinical trial STUDY001.

## 2. Study Objectives
### 2.1 Primary Objective
To evaluate the efficacy of Drug A compared to placebo in improving patient outcomes.

### 2.2 Secondary Objectives
- To evaluate the safety profile of Drug A
- To assess the effect on laboratory parameters
- To evaluate quality of life measures

## 3. Study Design
- Phase: II/III
- Design: Randomized, double-blind, placebo-controlled
- Sample Size: 50 subjects
- Randomization: 1:1:1 (Placebo:Drug A:Drug B)
- Duration: 12 weeks

## 4. Analysis Populations
### 4.1 Safety Population
All subjects who receive at least one dose of study medication.

### 4.2 Intent-to-Treat (ITT) Population
All subjects who are randomized and receive at least one dose.

### 4.3 Per Protocol (PP) Population
Subset of ITT population without major protocol violations.

## 5. Efficacy Analyses
### 5.1 Primary Endpoint
Change from baseline in primary efficacy parameter at Week 12.

### 5.2 Statistical Methods
- ANCOVA model with treatment as factor and baseline as covariate
- Two-sided 95% confidence intervals
- p-value < 0.05 for statistical significance

## 6. Safety Analyses
### 6.1 Adverse Events
- Summarize by treatment group
- Calculate incidence rates
- Compare between groups using chi-square test

### 6.2 Laboratory Parameters
- Summarize changes from baseline
- Identify shifts in toxicity grades
- Clinical significance assessment

## 7. Data Handling
### 7.1 Missing Data
- Primary analysis: Last Observation Carried Forward (LOCF)
- Sensitivity analysis: Mixed Effects Model

### 7.2 Outliers
- Pre-defined outlier criteria
- Sensitivity analyses excluding outliers

## 8. Software
- SAS Version 9.4
- R Version 4.2.0
- Validation procedures per SOP

## 9. Appendices
### 9.1 Data Definitions
- SDTM domain specifications
- ADaM dataset structures
- Variable definitions

### 9.2 Programming Standards
- CDISC compliance
- Validation checks
- Documentation requirements
